BioCentury
ARTICLE | Politics & Policy

In exit interview FasterCures’ Carino highlights patient engagement, new funding models

October 14, 2019 8:59 PM UTC
Updated on Oct 14, 2019 at 10:46 PM UTC

In an interview with BioCentury as she wraps up her time as head of FasterCures, Tanisha Carino highlighted initiatives to improve patient engagement in biomedical research, develop new models for commercializing therapies, and a public-private partnership to create biomedical innovation scorecards.

Carino will join Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) as EVP and chief corporate affairs officer on Nov. 4. ...

BCIQ Company Profiles

Alexion Pharmaceuticals Inc.